This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regents of the University of Minnesota. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Khalil Ahmed: Innovator in Antisense Therapy
Introduction
Khalil Ahmed is a notable inventor based in Minneapolis, MN. He has made significant contributions to the field of medical research, particularly in cancer treatment. His innovative work focuses on developing therapies that target specific molecular pathways to inhibit tumor growth.
Latest Patents
Khalil Ahmed holds 1 patent for his invention titled "Casein kinase 2 antisense therapy." This invention provides antisense oligonucleotides that hybridize to casein kinase 2 nucleic acid sequences. The methods described in the patent aim to inhibit the expression of casein kinase 2, which can lead to a reduction in the size of solid tumors.
Career Highlights
Khalil is affiliated with the University of Minnesota, where he conducts his research and development work. His role at the university allows him to collaborate with other experts in the field and contribute to advancements in cancer therapies.
Collaborations
Khalil has worked alongside notable colleagues such as Joel W. Slaton and Gretchen M. Unger. Their combined expertise enhances the research efforts and fosters innovation in the development of new therapeutic strategies.
Conclusion
Khalil Ahmed's work in antisense therapy represents a significant advancement in cancer treatment. His innovative approach has the potential to improve patient outcomes and contribute to the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile